|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.30 TWD | +9.98% |
|
+4.37% | +3.06% |
| Capitalization | 27.41B 853M 745M 673M 644M 1.17B 78.88B 1.22B 8.05B 3.19B 37.68B 3.2B 3.13B 136B | P/E ratio 2025 * |
-45.5x | P/E ratio 2026 * | - |
|---|---|---|---|---|---|
| Enterprise value | 27.35B 851M 744M 672M 643M 1.17B 78.71B 1.22B 8.03B 3.18B 37.6B 3.19B 3.13B 136B | EV / Sales 2025 * |
51.9x | EV / Sales 2026 * | - |
| Free-Float |
68.57% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 day | +9.98% | ||
| 1 week | +4.37% | ||
| Current month | -3.70% | ||
| 1 month | -1.55% | ||
| 3 months | -1.04% | ||
| 6 months | -19.64% | ||
| Current year | +3.06% |
| 1 week | 51.1 |  | 57.3 |
| 1 month | 51.1 | | 61.2 |
| Current year | 51.1 | | 76.7 |
| 1 year | 51.1 | | 82.7 |
| 3 years | 51.1 | | 241.44 |
| 5 years | 51.1 | | 282.94 |
| 10 years | 15.9 | | 398.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chih Hui Cheng
CEO | Chief Executive Officer | - | 20/06/2018 |
Shan Nei Huang
CEO | Chief Executive Officer | 82 | 25/06/2015 |
Wen Tzu Hsiao
DFI | Director of Finance/CFO | - | 30/09/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Hsien Shou Kuo
BRD | Director/Board Member | 84 | 25/04/2010 |
Shih Hua Hsu
BRD | Director/Board Member | - | 26/06/2012 |
Shan Nei Huang
CHM | Chairman | 82 | 25/06/2015 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -2.46% | 0.01% | 33,076 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +9.98% | +4.37% | -23.80% | -73.00% | 853M | |
| +0.80% | -0.53% | +21.09% | +201.18% | 880B | |
| -0.21% | +0.47% | +48.34% | +56.91% | 582B | |
| -2.52% | -4.53% | +3.74% | +42.79% | 388B | |
| +0.79% | -6.01% | +4.87% | +20.81% | 324B | |
| +0.11% | -0.83% | +19.89% | +34.57% | 295B | |
| +0.43% | -1.54% | +25.96% | +62.12% | 293B | |
| -0.26% | -0.16% | +22.25% | +8.08% | 286B | |
| -0.43% | -0.90% | +16.74% | +58.82% | 197B | |
| +0.42% | +0.74% | +30.11% | +81.76% | 180B | |
| Average | +0.91% | -0.39% | +16.92% | +49.40% | 342.7B | |
| Weighted average by Cap. | -0.02% | -1.37% | +22.84% | +84.77% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 527M 16.39M 14.33M 12.95M 12.39M 22.53M 1.52B 23.42M 155M 61.29M 724M 61.52M 60.22M 2.62B | - |
| Net income | -600M -18.67M -16.32M -14.74M -14.1M -25.65M -1.73B -26.66M -176M -69.78M -825M -70.04M -68.56M -2.98B | - |
| Net Debt | -60M -1.87M -1.63M -1.47M -1.41M -2.56M -173M -2.67M -17.61M -6.98M -82.48M -7M -6.86M -298M | - |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/03/26 | 57.30 NT$ | +9.98% | 6,951,699 |
| 12/03/26 | 52.10 NT$ | -2.25% | 1,991,261 |
| 11/03/26 | 53.30 NT$ | +1.52% | 1,019,015 |
| 10/03/26 | 52.50 NT$ | +0.19% | 1,196,642 |
| 09/03/26 | 52.40 NT$ | -4.55% | 2,390,367 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
57.30TWD
Average target price
308.00TWD
Spread / Average Target
+437.52%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4743 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition